共 18 条
[1]
Sarcoplasm ic reticu lum Ca2+trans-port and gene expression in congestive heart failure are mod ified by im id-april treatm ent. Shao Q,Ren B,Sain iHK,et al. American Journal of Physiology Heart and Circulatory Physiology . 2005
[2]
Early outcom es of acare coord ination-enhanced telehom e care program for elderly veteransw ith chron ic heart failure. Schofield RS,K line SE,Schmalfuss CM,et al. Telem ed J E Health . 2005
[3]
Preventing renal complications in diabetic patients:the diabetics exposed to tel misartan and enalaprIL(DETAIL)study. Barnett AH. Acta Diabetologica . 2005
[4]
Effect of fixed-dose ACE-inhibitor/calciumchannel blocker combi-nation therapy vs.ACE-inhibitor monotherapy on ar-terial compliance in hypertensive patients with type2diabetes. Winer N,Folker A,Murphy JA,et al. Preventive Cardiology . 2005
[5]
Postnatalmodu lation of prenatally programm ed hypertension by d ietary Na and ACE inh ib ition. Mann ing J,VehaskariVM. Am J PhysiolRegu l Integr Comp Physiol . 2005
[6]
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. Ishani A,Weinhandl E,Zhao Z,et al. Journal of the American College of Cardiology . 2005
[7]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[8]
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study*[J] . A. H. Barnett.  Acta Diabetologica . 2005 (1)
[9]
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction[J] . Areef Ishani,Eric Weinhandl,Zihong Zhao,David T. Gilbertson,Allan J. Collins,Salim Yusuf,Charles A. Herzog.  Journal of the American College of Cardiology . 2005 (3)